Drugs / eOD-GT8 60mer
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03547245 Comparator | Jun 2018 → Jan 2020 | HIV infectious disease | International AIDS Vaccine Initiative | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | eOD-GT8 60mer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03547245 ↗ |
| Modality | Vaccine | “eOD-GT8 60mer Vaccine, Adjuvanted” NCT03547245 ↗ |
| Route | Intramuscular | “eOD-GT8 60mer + AS01B/ DPBS sucrose/IM” NCT03547245 ↗ |